Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abigail Moore

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Genome Medicine|February 12, 2024
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trialGiselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, et al.
Health Technology Assessment (Winchester, England)|June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trialHamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Journal of Psychopharmacology (Oxford, England)|January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Molecular Ecology|May 20, 2026
Population Genomics of a Cosmopolitan Weed Provides Insights Into Its Local Adaptation and Recent Demographic HistoryMarilia Souza Lucas, Christoph Rosche, Isabell Hensen, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Genome Medicine|February 12, 2024
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trialGiselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, et al.
Health Technology Assessment (Winchester, England)|June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trialHamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Journal of Psychopharmacology (Oxford, England)|January 20, 2025
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Molecular Ecology|May 20, 2026
Population Genomics of a Cosmopolitan Weed Provides Insights Into Its Local Adaptation and Recent Demographic HistoryMarilia Souza Lucas, Christoph Rosche, Isabell Hensen, et al.
Pageof 4